trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Aids patients with pneumocystis carinii pneumonia have a higher survival rate when treated with glucocorticosteroids than with placebo.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that aids patients with pneumocystis carinii pneumonia have a higher survival rate when treated with glucocorticosteroids than with placebo?

Yes. Clinical evidence from randomized trials and meta-analyses indicates that adjunctive corticosteroid treatment improves survival rates in AIDS patients with Pneumocystis pneumonia compared to placebo or standard care alone.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

Multiple high-quality sources, including a Cochrane systematic review of randomized trials, confirm that adjunctive glucocorticosteroids significantly reduce mortality in HIV patients suffering from Pneumocystis pneumonia with substantial hypoxemia. No retrieved papers refute this established finding in the HIV population.

Evidence for · 2
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.
2015
A Cochrane systematic review and meta-analysis of randomized controlled trials shows that adjunctive corticosteroids significantly reduce overall mortality and the need for mechanical ventilation in HIV-infected patients with Pneumocystis pneumonia presenting with hypoxaemia.
Get citation
H, E., H, R., R, B., H, F., HC, B., & M, B. (2015). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection.. doi.org. https://doi.org/10.1002/14651858.cd006150.pub2

See more details
More for · 1
Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.
2026
Recent clinical literature affirms that adjunctive corticosteroids have demonstrated a clear mortality benefit in AIDS-associated severe Pneumocystis jirovecii pneumonia compared to standard treatment alone.
Get citation
JA, M., PO, N., IG, B., LF, M., N, S., CC, S., V, A. G., AJ, F., LM, M., GS, M., & LF, R. (2026). Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practice.. doi.org. https://doi.org/10.1186/s41479-026-00202-5

What does the evidence say?

Multiple high-quality sources, including a Cochrane systematic review of randomized trials, confirm that adjunctive glucocorticosteroids significantly reduce mortality in HIV patients suffering from Pneumocystis pneumonia with substantial hypoxemia. No retrieved papers refute this established finding in the HIV population.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work